Rice Hall James & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medpace
MEDP
|
+$24.7M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$21.7M |
| 3 |
FOLD
Amicus Therapeutics
FOLD
|
+$12.1M |
| 4 |
Prestige Consumer Healthcare
PBH
|
+$11.6M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$51M |
| 2 |
Etsy
ETSY
|
+$38.3M |
| 3 |
AIMT
Aimmune Therapeutics
AIMT
|
+$33.6M |
| 4 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
+$19.5M |
| 5 |
Trade Desk
TTD
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.47% |
| 2 | Technology | 23.43% |
| 3 | Industrials | 17.34% |
| 4 | Consumer Discretionary | 13.01% |
| 5 | Communication Services | 6.59% |
Similar funds
Rice Hall James & Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.
- Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
- Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
- Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
- Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
- Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
- Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
- Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.
Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.